Intelligence · Patents
Patents expiring in 2036
Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.
- Patents
- 1,428
Quick answer
1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9278088
Methods for identifying analgesic agents
granted -
US 9278066
Topical pharmaceutical foam composition
granted -
US 9278901
Compounds and methods for delivery of prostacyclin analogs
granted -
US 9277799
Henna applicator device and a method of operating the same
granted -
US 9283194
Methods for protease assisted protein delivery
granted -
US 9283220
Compositions of opioid antagonists and methods for treating conditions caused by the varicella-zoster virus therewith
granted -
US 9284356
Identification of a west nile virus CD4 T cell epitope and use thereof
granted -
US 9283183
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 9283256
Antibacterial composition comprising Salvia extracts
granted -
US 9283185
Liposomal curcumin for treatment of cancer
granted -
US 9283300
Use of midkine protein and the protein-containing medical device
granted -
US 9284546
Human cystathionine beta-synthase variants and methods of production thereof
granted -
US 9284380
Anti-ErbB3 antibodies and uses thereof
granted -
US 9283238
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted -
US 9283179
GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9284543
Neutral active soluble truncated PH20 polypeptides and uses thereof
granted -
US 9284411
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
granted -
US 9283358
Drug releasing coatings for medical devices
granted -
US 9284367
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9284276
N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereof
granted -
US 9283233
Method for on-demand contraception
granted -
US 9284251
Complex zinc and alpha-chlorocarboxylic acid compounds for treating skin lesions
granted -
US 9290456
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 9290541
TCL1 peptides for immunotherapy
granted -
US 9289504
Single protein nanocapsules for protein delivery with long-term effect
granted -
US 9290574
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor
granted -
US 9289398
Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
granted -
US 9290757
Protease screening methods and proteases identified thereby
granted -
US 9289514
Low density lipoprotein receptor-mediated siRNA delivery
granted -
US 9290760
Modified iRNA agents
granted -
US 9290752
Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts
granted -
US 9290572
Integrin α-Vβ8 neutralizing antibody
granted -
US 9290474
Methods for making and using novel semi-synthetic small molecules for the treatment parasitic disease
granted -
US 9290562
Transferrin-tumstatin fusion protein and methods for producing and using the same
granted -
US 9290491
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted -
US 9290512
Activators of human pyruvate kinase
granted -
US 9289468
Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof
granted -
US 9289539
Drug releasing coatings for medical devices
granted -
US 9289513
Targeted cytokine for treatment of musculoskeletal diseases
granted -
US 9289537
Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids
granted -
US 9289500
Saccharide-peptide hydrogels
granted -
US 9289131
Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles
granted -
US 9289451
Methods and compositions for targeted cleavage and recombination
granted -
US 9289408
High concentration baclofen preparations
granted -
US 9290539
Melanotropin ligands for skin care
granted -
US 9289382
Vaginal inserted estradiol pharmaceutical compositions and methods
granted -
US 9296798
Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods
granted -
US 9297009
UNA oligomers targeting micro-RNA for therapeutics
granted
Frequently asked questions
How many pharma patents expire in 2036?
1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.